论文部分内容阅读
金陵药业经营情况保持平稳,资金充裕且主要投资于主业领域。脉络宁已经进入基本药物目录,加之宿迁医院的持续盈利将成为公司增长的动力源泉。
Jinling Pharmaceutical business remained stable, well-funded and mainly invested in the main areas of business. Mailuoning has entered the list of essential medicines, combined with the continued profitability of Suqian Hospital will become the source of growth momentum for the company.